SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,693,150 | -28.2% | 13,968 | -32.2% | 0.00% | -25.0% |
Q2 2023 | $2,357,611 | -30.6% | 20,588 | -16.5% | 0.00% | -33.3% |
Q1 2023 | $3,398,929 | +214.4% | 24,661 | +196.1% | 0.01% | +200.0% |
Q4 2022 | $1,081,031 | +133.0% | 8,329 | +97.9% | 0.00% | +100.0% |
Q3 2022 | $464,000 | +41.0% | 4,209 | -4.4% | 0.00% | 0.0% |
Q2 2022 | $329,000 | -13.0% | 4,402 | -9.0% | 0.00% | 0.0% |
Q1 2022 | $378,000 | -20.4% | 4,838 | -8.1% | 0.00% | 0.0% |
Q4 2021 | $475,000 | -24.4% | 5,263 | -22.6% | 0.00% | 0.0% |
Q3 2021 | $628,000 | +11.0% | 6,799 | -6.7% | 0.00% | 0.0% |
Q2 2021 | $566,000 | +13.2% | 7,287 | +8.6% | 0.00% | 0.0% |
Q1 2021 | $500,000 | -44.7% | 6,709 | +26.5% | 0.00% | -50.0% |
Q4 2020 | $904,000 | +1.9% | 5,304 | -16.0% | 0.00% | -33.3% |
Q3 2020 | $887,000 | -3.3% | 6,318 | +10.4% | 0.00% | 0.0% |
Q2 2020 | $917,000 | +53.9% | 5,724 | -57.4% | 0.00% | +50.0% |
Q1 2020 | $596,000 | – | 13,424 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |